Sign inGet started

Product

Solutions

Data

Developers

Pricing

Best FDA Regulatory Guidance Newsletters in 2026

NewsletterFIT tracks 3 newsletters that cover FDA regulatory guidance as a primary topic, all with posts in the last 90 days. By publicly shown subscriber count, the largest are The FDA Group's Insider Newsletter (8K), Let's Talk Risk! (4K) and Operating in Healthtech by Arvita Tripati (1K).

Updated Nov 13, 2026 · sorted by publicly shown subscribers · methodology

  1. 1
    The FDA Group's Insider Newsletter8K subscribers

    SubstackSeveral times a week · last post 13 days ago

    From recent posts: The FDA Group's Insider Newsletter publishes biweekly regulatory updates, compliance case studies, and expert interviews for life science professionals navigating FDA guidance, quality audits, and therapeutic approvals…

    Likely audience: Regulatory affairs professionals

  2. 2
    Let's Talk Risk!4K subscribers

    SubstackSeveral times a week · last post 10 days ago

    From recent posts: Let's Talk Risk! publishes a mix of FDA regulatory guidance and practical quality management content for medical device professionals. Recent issues balance technical QMSR deep-dives—such as process agent residues…

    Likely audience: Quality Assurance Managers

  3. 3
    Operating in Healthtech by Arvita Tripati1K subscribers

    SubstackWeekly · last post 9 days ago

    What it takes to build healthcare technology that survives enterprise procurement, regulation, and reality. For investors, operators, and founders building in regulated healthcare and AI.

    Likely audience: Product managers in healthtech

Latest posts from these newsletters

Browse all topics